West Pharmaceutical Services Inc. (WST)
NYSE
366.48
-6.16 (-1.65%)
Closed
Oct 7, 2026
Day's Range
365.35374.79
52 wk Range
223.83386.00
Financial Statements - WST - West Pharmaceutical Services Inc.
Revenue
3.07B▲ 6.3%
Net Income
493.70M▲ 0.2%Net Margin 16.1%
EBITDA
822.70M▲ 7.7%
Free Cash Flow
468.90M▲ 69.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.07B | 2.89B | 2.94B | 2.88B | 2.83B | 2.14B |
| Cost of Goods | 1.97B | 1.89B | 1.82B | 1.75B | 1.65B | 1.37B |
| Gross Profit | 1.10B | 998.50M | 1.12B | 1.13B | 1.17B | 767.80M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 636.10M | 590.90M | 707.40M | 760.80M | 760.20M | 418.90M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -52.20M | -22M | -28.40M | -78.10M | -4.10M | -10.80M |
| Pre Tax Income | 600.90M | 585.50M | 698M | 679.90M | 748.90M | 401.30M |
| Income Tax | 121.60M | 107.50M | 122.30M | 114.70M | 107.20M | 72.50M |
| Net Income | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M | 346.20M |
| EPS Basic | 6.83 | 6.75 | 7.98 | 7.87 | 8.89 | 4.68 |
| EPS Diluted | 6.79 | 6.69 | 7.88 | 7.73 | 8.67 | 4.57 |
| Basic Shares Outstanding | 72.30M | 73M | 74.30M | 74.40M | 74.40M | 73.90M |
| Diluted Shares Outstanding | 72.30M | 73M | 74.30M | 74.40M | 74.40M | 73.90M |
| Ebit | 601.40M | 588.50M | 707M | 687.80M | 757.10M | 409.50M |
| Ebitda | 822.70M | 764M | 875.70M | 835.80M | 885.60M | 530.60M |
| Net Income Continuous Operations | 493.70M | 492.70M | 593.40M | 585.90M | 661.80M | 346.20M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
